Mayne Pharma Price Target Cut 37% to A$3.83/Share by Canaccord Genuity
DO Dow Jones Newswires Mayne Pharma Price Target Cut 37% to A$3.83/Share by Canaccord Genuity 7/3/2026, 07:25 AM GMT+8 Dow Jones Newswires MY MYX Mayne Pharma Price Target Cut 37% to A$3.83/Share by Canaccord Genuity Market News Dow Jones Newswires Mayne Pharma Moved to Speculative Buy from Buy by Canaccord Genuity
